Companies: 10,795·Total market cap: $144.5T

Revolution Medicines, Inc.

Revolution Medicines, Inc.

RVMDNASDAQHealthcare● Active

$149.23

$-6.46(-4.15%)

Market Cap$31.7B

P/E Ratio—

52W High$166.5

52W Low$34

Avg Volume3.0M

Open$153.67

Beta1.41

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Revolution Medicines, Inc.（RVMD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RVMD · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-7.11Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding190.1MShares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 Revolution Medicines, Inc. 数据

分析师预测$165 · Buy

股息不分红

盈利EPS $-5.95-66.20%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$1.13B▼ 88.52% YoY

202320242025

FY 2025EPS$-5.95▼ 66.20% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$1.37BEPS: $-7.11View income statement →

分析师评级与目标价

Buy22 位分析师

Strong Buy

1

Buy

20

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$73.00Low

$149.23Current

$165.33Avg Target上涨空间 10.79%

$205.00High

合计: 22 · 买入占比: 95.5%

根据过去 3 个月内 22 位华尔街分析师，RVMD 共识评级为 Buy，12 个月平均目标价 $165.33 （较现价 $149.23 上涨空间 10.79%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Revolution Medicines, Inc.

$149.23-4.15%$31.7B #2

Ascendis Pharma A/S

$210.45-1.32%$13.0B #3

BridgeBio Pharma, Inc.

$67.61-0.33%$13.2B #4

BioMarin Pharmaceutical Inc.

$56.77+0.07%$11.0B #5

$52.70+0.11%$13.2B #6

Ionis Pharmaceuticals, Inc.

$74.48-0.47%$12.3B

股票表现

1D-4.15%

1W-1.54%

1M+5.23%

3M+51.66%

YTD+87.36%

1Y+267.74%

5Y+362.16%

关于 Revolution Medicines, Inc.

CEOMark A. Goldsmith

IPO DateFeb 13, 2020

Employees616

CountryUS

Websiterevmed.com

Revolution Medicines, Inc. a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inh…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Revolution Medicines, Inc.（RVMD）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 13, 2020 在 NASDAQ 上市。截至最近交易日，RVMD 股价为 $149.23，市值约为 $31.7B。过去12个月累计回报 +267.74%，年初至今回报 +87.36%。

根据 22 位华尔街分析师，Revolution Medicines, Inc. 股票共识评级为Buy，12个月平均目标价为 $165.33。2025 财年 Revolution Medicines, Inc. 营收 —，净利润 -$1.1B。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Revolution Medicines, Inc.（RVMD）股价为 $149.23，在 NASDAQ 上市，52周区间为 $34.00 – $166.50。

RVMD 最新股价RVMD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议